Objective Hantaviruses are health threatening infectious agents causing hemorrhagic fevers with renal syndrome in humans. In Europe, the hantaviruses Pamela and Do Brava have been identified as the main pathogens. There is an urgent need for a development of a bivalent vaccine protecting occupational risk groups and inhabitants of hyper endemic regions against infections by these two viruses. Fields of science natural sciencesbiological sciencesmicrobiologyvirologymedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsvaccines Programme(s) FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002 Topic(s) 1.1.1.-2. - Key action Control of Infectious Diseases Call for proposal Data not available Funding Scheme CSC - Cost-sharing contracts Coordinator HUMBOLDT-UNIVERSITAET BERLIN EU contribution No data Address Schumannstraße 20/21 10117 Berlin Germany See on map Total cost No data Participants (4) Sort alphabetically Sort by EU Contribution Expand all Collapse all INSTITUTE OF BIOTECHNOLOGY Lithuania EU contribution No data Address Graiciuno Street 8 2028 VILNIUS See on map Total cost No data SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL Sweden EU contribution No data Address Nobels vaeg 18 SOLNA See on map Links Website Opens in new window Total cost No data UNIVERSITY OF HELSINKI Finland EU contribution No data Address Yliopistonkatu 4 00014 HELSINKI See on map Total cost No data UNIVERSITY OF UMEAA Sweden EU contribution No data Address Universitetsomraadet 901 87 UMEAA See on map Total cost No data
